Anzeige
Meldung des Tages: Gold dreht wieder auf: Goldpreis-Comeback – und diese Bohrung liefert 307 Meter „Gold-System“

Kadimastem Ltd News

Aktie
WKN:  ISIN:  IL0011284614 US-Symbol:  KMSTF
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
100,00%
KGV
-
Index-Zuordnung
-

Kadimastem Ltd News

29.10.25 - PR Newswire
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares PR Newswire
10.09.25 - PR Newswire
Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger
Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger PR Newswire
04.09.25 - PR Newswire
NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients
NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-​Selection and Enrichment Technology for IsletRx for Diabetes Patients PR Newswire
17.07.25 - PR Newswire
NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for Continued Co-Development of Type 1 Diabetes Cell Therapy
NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for ...
16.06.25 - PR Newswire
NLS Pharmaceutics CEO Issues Letter to Shareholders
NLS Pharmaceutics CEO Issues Letter to Shareholders PR Newswire
15.04.25 - PR Newswire
NLS Pharmaceutics Announces Positive Results from Study KO-943 Demonstrating Mazindol Reduces Fentanyl-Induced Reward in Animal Models
NLS Pharmaceutics Announces Positive Results from Study KO-943 Demonstrating Mazindol Reduces Fentanyl-​Induced Reward in Animal Models PR Newswire

Newssuche

Videos

newspaper
03.02.26
2026 02 03 17 34 Trendjumper Einführung
Zunächst inormieren wir unsere Stammkunden bezüglich des bevorstehenden Seminars und bieten für ... Mehr »